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It is 10 years since severe acute respiratory syndrome 
(SARS) emerged, and East and Southeast Asia retain a 
reputation as a hot spot of emerging infectious diseases. 
The region is certainly a hot spot of socioeconomic and 
environmental change, and although some changes (e.g., 
urbanization and agricultural intensification) may reduce the 
probability of emerging infectious diseases, the effect of any 
individual emergence event may be increased by the great-
er concentration and connectivity of livestock, persons, and 
products. The region is now better able to detect and re-
spond to emerging infectious diseases than it was a decade 
ago, but the tools and methods to produce sufficiently re-
fined assessments of the risks of disease emergence are 
still lacking. Given the continued scale and pace of change 
in East and Southeast Asia, it is vital that capabilities for 
predicting, identifying, and controlling biologic threats do not 
stagnate as the memory of SARS fades.
It is a decade since severe acute respiratory syndrome (SARS) emerged and in a few dramatic months redefined 
perceptions of global vulnerability to emerging infectious 
diseases. It is believed that SARS originated from southern 
China, with the first cases identified in Guangdong Province, 
China, where sporadic cases and small outbreaks occurred 
between November 2002 and early January 2003. A larger 
outbreak, triggered by nosocomial transmissions in 2 hospi-
tals, began during mid-January 2003 in Guangzhou city, the 
capital of Guangdong Province (1). On February 11, 2003, 
the international community, including the World Health Or-
ganization (WHO), became aware of this unusual cluster of 
severe pneumonia cases, which included many health care 
workers. Detailed information about the outbreak was not 
available to the international community, and when WHO is-
sued a global alert on March 12, 2003, the virus had already 
spread to other countries and caused outbreaks in areas out-
side Guangdong, including Hong Kong, China; Hanoi, Viet-
nam; Singapore; and Toronto, Ontario, Canada.
The SARS epidemic provided a dramatic demonstra-
tion of the weaknesses in national and global capacities to 
detect and respond to emerging infectious diseases, and it 
was in many ways a watershed event that had a transfor-
mative effect on many of the clinical, public health, and 
other professionals involved. But has the response to SARS 
had any lasting effect on the probability of new infectious 
agents emerging, being detected at an early stage of emer-
gence, and being effectively controlled?
More than 30% of the global population lives in East 
and Southeast Asia, and despite impressive improvements 
in health, infectious diseases remain a major problem 
in the region. In 2010, 47% of the estimated 2.1 million 
deaths among children <5 years of age in Southeast Asia 
were attributable to infectious diseases (e.g., pneumonia 
and acute diarrhea) (2). Alongside this existing pool of 
known human pathogens, a large and diverse population 
of mammalian wildlife species and domestic livestock re-
side in the region, acting as reservoirs or amplifying spe-
cies from which new infectious diseases of humans might 
emerge (3,4). The reemergence of highly pathogenic avian 
influenza A(H5N1) virus in 2004, the isolation of novel 
bat-associated reoviruses from humans in Malaysia in 
2006, and the discovery of a novel tick-borne bunyavirus 
associated with fever and thrombocytopenia in rural farm-
ers in China in 2009 attest to the existence of a pool of 
potential zoonotic pathogens in East and Southeast Asia 
(Table) (8,9,12). We review how the conditions that drive 
the emergence of infectious diseases and the systems to de-
tect and control them have changed in East and Southeast 
Asia in the decade since SARS.
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Over the past decade, East and Southeast Asia have 
been home to many of the top-performing world econo-
mies, and this macroeconomic success has resulted in large 
increases in the demand for natural resources. The demand 
for hardwood, firewood, wood pulp, agricultural and graz-
ing land, living space, roads, minerals, and power has had 
an enormous effect on the ecosystems of the region. De-
forestation occurred throughout the 1990s, but the last de-
cade has seen net increases in forested areas of China, the 
Philippines, and Vietnam because of active afforestation 
(including new commercial plantations). Net forest losses 
continue, however, in Myanmar, Cambodia, Indonesia, and 
Papua New Guinea (Figure 1) (13).
The conversion of natural environments into agricul-
tural or other commercially viable land (e.g., dams, mines) 
is usually associated with a decrease in biodiversity. A re-
duction in biodiversity can lead to increased disease trans-
mission through a variety of mechanisms (e.g., reduced 
predation and competition) and cause an increase in the 
abundance of competent hosts and the loss of buffering 
species, leading to increased contact between amplifying 
host species and compatible pathogens (14). Although a re-
duction in biodiversity can lead to increased disease trans-
mission, a large diversity of mammalian wildlife species 
is also associated with a large diversity of microbial spe-
cies, which both increase toward the equator (3,4). There-
fore, tropical areas (e.g., Myanmar, Cambodia, and parts of 
Indonesia) that have a rich pool of existing and potential 
pathogens but are experiencing ongoing ecosystem disrup-
tion and biodiversity loss may be at a particularly high risk 
for the emergence of zoonotic diseases.
Land-use changes are ongoing, but much of East and 
Southeast Asia already has very high pressures on produc-
tive land. The rate of land-use change in much of the region 
has probably peaked, and the region is now in an era of 
increasing intensification of land productivity. In fact, over 
the last decade, China has increased agricultural output de-
spite a slight decrease in total agricultural land area (Figure 
2) (15). This intensification is driven largely by demograph-
ic pressures, which are predicted to result in a 70% increase 
in food production by 2050; the consumption of grains is 
expected to decrease and demand for meats, fruits, and veg-
etables is expected to increase (15). The recent high and 
volatile prices for food commodities are a good indicator of 
the current vulnerability of agricultural production systems.
The environmental consequences of intensified agri-
cultural production include the depletion and degradation 
of river and groundwater, reduced soil quality, and water 
and soil contamination with chemical fertilizers and pesti-
cides. The loading of aquatic ecosystems with nitrogen and 
phosphorous (eutrophication) is a widespread environmen-
tal change with an as-yet unquantified effect on the risk for 
disease emergence. Eutrophication can result in potentially 
harmful blooms of cyanobacteria, but little is known about 
the effect on pathogens that cause disease in animals and 
humans. There is, however, evidence that eutrophication 
can alter ecosystems in such a way as to increase the trans-
mission of parasitic diseases of amphibians, the concentra-
tion of Vibrio cholerae, and the abundance of mosquito 
vectors (16). Given the trend of increasing intensification 
of crop and animal production in East and Southeast Asia, 
much more attention should be given to the effect of the 
large-scale contamination of water and soil with nitrogen, 
phosphorous, and other chemicals on the functioning of 
ecosystems and on disease dynamics.
Livestock Production
Demand for livestock products in East and Southeast 
Asia has risen dramatically over the past 50 years: the per 
capita consumption of meat in developing countries has more 
than tripled since the early 1960s, and egg consumption has 





Table. Emerging and reemerging infectious disease events detected in East and Southeast Asia, 2004–2011* 
Year, pathogen Pathogen type Driver of resistance Location Ref 
2004     




2005     
 Streptococcus suis serotype 2 Bacteria Agricultural industry changes/co-infection with 
porcine reproductive and respiratory syndrome virus 
China/Vietnam  (6,7) 
2006     
 Melaka virus Reovirus Improved detection Malaysia  (8) 
 Kampar virus Reovirus Improved detection Malaysia  (9) 
2009     
 Artemisinin-resistant malaria Protozoa Artemisinin or artesunate monotherapy Cambodia  (10) 
 Reston Ebola virus† Filovirus Improved detection/co-infection with porcine 
reproductive and respiratory syndrome virus 
Philippines  (11) 
 Severe fever with  
 thrombocytopenia syndrome 
Bunyavirus Unknown China  (12) 
*Ref, reference. 
†Detected in swine but not shown to cause human disease. 
 
Prospects for Emerging Infections 10 Years after SARS
increased 5-fold (17). The increased demand for meat has 
been met by more intensive and geographically concentrated 
production of livestock, especially pigs and poultry. East and 
Southeast Asia are home to 569 million pigs (60% of the 
world pig population) and 9.2 billion poultry (43% of the 
world poultry population) (18). The Food and Agriculture 
Organization of the United Nations (FAO) has projected that 
pork consumption in China will increase by 55% between 
2000 and 2030 (19), and Rabobank, an agricultural finance 
group, predicts a 45% increase in global meat demand over 
the next 20 years, with 70% of that occurring in Asia. The 
demand will be particularly strong for poultry because of its 
relatively low cost and short production cycle, and because 
there are fewer cultural restrictions regarding poultry than 
there are that concern pork and beef.
In addition, meat-producing companies will continue 
to consolidate at the global level. The intensification of 
livestock farming often results in more effective separa-
tion of domestic and wild animals, improved veterinary 
supervision and input, reduced movement of animals, and 
reduced species mixing, all of which may reduce the likeli-
hood of disease emergence. However, higher densities of 
short production–cycle domestic animals, such as pigs and, 
in particular, poultry, introduce a vulnerability because 
such animals usually have limited genetic variation. Higher 
genetic diversity within a host species is often associated 
with differences in susceptibility to infection, thereby lim-
iting the potential for infections to spread rapidly (20). Re-
cent outbreaks of highly pathogenic porcine reproductive 
and respiratory syndrome virus throughout East and South-
east Asia, which at times co-occurred with outbreaks of 
Streptococcus suis infections, and the detection of Reston 
Ebola virus infection in pigs in the Philippines highlight 
the ongoing risk for disease emergence, amplification, and 
crossover from livestock to humans in East and Southeast 
Asia (6,11).
In East and Southeast Asia, antimicrobial drugs are 
used extensively in the livestock and aquaculture sectors to 
treat or prevent infections, and they are used non-therapeu-
tically as growth promoters, which requires the prolonged 
administration of sub-therapeutic doses. This practice has 
a demonstrable effect on the emergence and prevalence 
of potentially clinically relevant resistant microorganisms 
in food animals. Furthermore, the subsequent excretion of 
antimicrobial drugs into the environment may subject en-
vironmental bacteria to antimicrobial selection pressures 
(21). It is clear that the continued use of non-therapeutic 
antimicrobial drugs in livestock and aquaculture industries 
that are increasing in scale and intensity poses a threat to 
human and animal health (22).
Wildlife and Farm Biosecurity
Reducing contact between domestic and wild animals, 
whether the wild animals remain wild or are captive in 
breeding farms or markets, is a key tactic recommended 
by the FAO for reducing risk to human health, and this re-
duced contact is part of the wider FAO strategy for biosecu-
rity. Improving biosecurity in farms in East and Southeast 
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Figure 1. Annual change in forest 
area by country, 2005–2010. Source: 
Food and Agriculture Organization 
of the United Nations Global Forest 
Resources Assessment 2010 (www.
fao.org/forestry/fra/fra2010/en/).
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Asia is a major challenge because a large proportion of the 
farming is done in backyard and small- to medium-scale 
commercial farms, and there is often a mix of commercial 
and backyard farming in any 1 location (23). The longer-
term vision is to restructure the livestock production sector 
toward a more integrated and controlled system in which 
controls benefit animal health and welfare, human health, 
and commercial profitability without adversely affecting 
the livelihood of poor persons.
In East and Southeast Asia, increasing intensification 
of animal husbandry may lead to healthier, better isolated 
animals and a subsequent lowered risk for emerging dis-
ease events. However, should an emerging infectious dis-
ease event occur, this intensification may result in greater 
amplification of disease in large, naive monocultures, as 
demonstrated in the Netherlands when they experienced 
major outbreaks of classical swine fever in 1997–1998 and 
avian influenza in 2003. The role of civet cats in the SARS 
pandemic and the smuggling of avian influenza A(H5N1) 
virus–infected birds of prey into Europe showed that the 
legal and illegal wildlife trade is an effective conduit for 
zoonotic pathogens to enter new niches (24,25). Wild ani-
mal products remain popular in East and Southeast Asia as 
traditional medicines, tonics, food delicacies, or symbols 
of wealth. Although all 10 countries in the Association of 
Southeast Asian Nations (ASEAN) are signatories to the 
Convention on International Trade in Endangered Species 
of Wild Fauna and Flora, Asia continues to host the largest 
illegal wildlife trade in the world (26).
Travel and Trade
The regional and global connectivity of East and 
Southeast Asia continues to increase; there is visa-free 
travel between ASEAN countries, relaxation of previously 
restrictive international travel policies in some countries, 
and a proliferation of budget airlines. Increased travel and 
trade between Africa and Asia is a particularly notable phe-
nomenon: exports from Africa to Asia increased 20% from 
2003 to 2008. This Africa–Asia traffic is a new corridor for 
the exchange of potential emerging infectious pathogens.
The ongoing development of a regional road transport 
network within East and Southeast Asia will also offer new 
opportunities for pathogen dispersal because, compared 
with air travel, roads offer a more egalitarian form of con-
nectivity that includes animals as well as humans. Increases 
in domestic travel also continue; only 10% of the world is 
now classified as remote (i.e., >48 hours travel time to a 
big city), and an estimated 2.5 billion passenger trips were 
made during China’s 2011 Lunar New Year celebrations—
the greatest annual human migration on earth. Increased 
connectivity provides greater opportunities for pathogens 
to disperse beyond their traditional niches and presents a 
formidable challenge to the tracking and containment of 
outbreaks (27).
Urbanization, Human Demographics, and Behavior
Between 2011 and 2050, the global population is ex-
pected to increase from 3.6 billion to 6.3 billion (an increase 
of 2.6 billion [72%]), and this increase will be concentrated 
in cities (28). Most of the growth will occur in develop-
ing countries, particularly in Asia, which will experience 
an increase in its urban population of 1.4 billion persons. 
In many ways, this concentration of population growth in 
urban areas is a positive development, and the popularity of 
cities is a testament to the fact that cities generally provide 
better economic and education opportunities, better living 
and sanitation conditions, better nutrition, and therefore 
better health than in underdeveloped rural areas.
Cities are, however, key in the epidemiology of many 
infectious diseases because they can function as “pace-mak-
ers” that drive temporal and spatial transmission dynamics 
of local epidemiology (e.g., dengue), hubs for national and 
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Figure 2. China’s cereal pro-
duction yield and arable land 
area, 1999–2009. Source: The 
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global spread (e.g., SARS and HIV), or bridges between 
human and animal ecosystems (e.g., influenza A subtypes 
H5N1 and H7N9). East and Southeast Asia have made 
considerable progress in health and social welfare improve-
ments: during 2000–2010, a total of 125 million persons in 
China and India moved out of slum conditions. However, 
urban poverty remains a concern. In 2010, an estimated 500 
million persons in Asia lived in slums (29), and, at the end 
of 2008, there were an estimated 140 million rural migrant 
workers in China, many of whom lacked residency rights 
and had limited access to health care and other social sup-
ports (30). Circular migration between rural and urban set-
tings is common and may facilitate the transfer of pathogens 
from wild or rural ecosystems to urban areas, with the po-
tential for rapid amplification in settings with high concen-
trations of migrant workers.
Health Systems
Almost 35% of the emerging infectious diseases identi-
fied in Asia during 1940–2004 represent the emergence of a 
new pattern of antimicrobial drug resistance (4). The major 
driver of such resistance is drug pressure. In East and South-
east Asia, the sequential development of resistance by ma-
laria parasites to chloroquine, sulfadoxine-pyrimethamine, 
mefloquine, and now artemisinin is a measure of both the 
adaptive capacity of the parasite and the failure of health 
systems to implement effective drug combination and cycling 
strategies to avoid resistance. Bacteria in East and Southeast 
Asia show high rates of resistance to antimicrobial agents; 
examples include multidrug-resistant Acinetobacter bau-
mannii, Salmonella enterica, and Enterobacteriaceae (31). 
A high level of antimicrobial resistance is a marker of the 
failure to control access to antimicrobial drugs and to influ-
ence prescribing behaviors. Over-the-counter antimicrobial 
drugs are available without a prescription throughout much 
of East and Southeast Asia, even though antimicrobial drugs 
are officially prescription-only medicines in most countries. 
Left unchecked, the supply- and demand-side incentives for 
inappropriate antimicrobial drug use will lead to a region 
awash with antimicrobial drugs and with the potential for 
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Figure 3. Self-reported global and regional average attribute scores for international health regulations core capacities, 2011. Source: 
World Health Organization, Summary of 2011 States Parties Report on International Health Regulations Core Capacity Implementation. 
(www.who.int/ihr/publications/WHO_HSE_GCR_2012.10eng/en/index.html). The attribute score is the percentage of attributes (a set of 
elements or functions that reflect the level of performance or achievement of an indicator) in which moderate or strong technical capacity 
has been attained in each core capacity area. SEAR results are the average for 11/11 eligible countries. WPR results are the average for 
19/27 eligible countries (8 countries did not complete the questionnaire in 2011). SEAR, World Health Organization’s (WHO) South-East 
Asia Region; WPR, WHO Western Pacific Region.
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public health disasters, such as artemisinin resistance, which 
now threatens global malaria control.
Surveillance and Response
The SARS pandemic highlighted what had been ap-
parent to some since the 1990s: few countries possessed 
the necessary surveillance and response capacities to 
rapidly detect and control emerging infectious diseases 
(32). The deficiencies of the 1969 International Health 
Regulations at the global level had long been recognized, 
and attempts to revise them were ongoing before 2003, 
but the SARS outbreak added new urgency and momen-
tum for change. The International Health Regulations 
were successfully revised in 2005, and for the first time 
they defined a series of core capacities that each coun-
try is required to establish to detect, report, and control 
public health emergencies of international concern. The 
target for attaining these core capacities was set as June 
2012, and an assessment undertaken in 2011 found that 
although these core capacities had not yet been fully 
achieved in several countries of East and Southeast Asia, 
considerable progress had been made (Figure 3) (33). For 
example, the influenza surveillance network in China ex-
panded from 63 laboratories and 197 sentinel hospitals 
in 2005 to 441 laboratories and 556 sentinel hospitals in 
2009 (34). Field epidemiology training programs have 
played a central role in strengthening epidemiology ca-
pacity in human and animal health, and new field epi-
demiology training programs were implemented in Laos, 
Mongolia, and Vietnam in 2009 and in Cambodia in 
2011 (35). An analysis of the global capacity for detect-
ing outbreaks showed improvements in the median time 
from outbreak start to outbreak discovery between 1996 
(29.5 days) and 2009 (13.5 days) and from start to public 
communication (40 days in 1996 to 19 days in 2009); the 
WHO Western Pacific Region was the only WHO region 
that showed a statistically significant improvement in 
both areas (36).
Many of these improvements were facilitated by a 
large increase in political and financial support for emerg-
ing infectious disease surveillance and response from na-
tional governments and donor agencies after the outbreaks 
of SARS and influenza A(H5N1). Although data on the 
total expenditure for emerging infectious disease surveil-
lance, preparedness, and response in East and Southeast 
Asia are not available, examples of international support 
include the first and second Asian Development Bank 
Greater Mekong Subregion Regional Communicable Dis-
eases Control Projects ($38.75 million and $49 million, 
respectively), the Canada–Asia Regional Emerging Infec-
tious Disease Project ($4.3 million), the US Government 
foreign assistance for disease control, research, and train-
ing (>$500 million in Asia during 2004–2011), and the US 
Agency for International Development’s Pandemic and 
Emerging Threats Program. As a consequence, pandemic 
and epidemic preparedness planning has improved in most 
countries of East and Southeast Asia, but gaps between the 
plans and the ability to operationalize them remain in many 
countries (37,38).
Since 2003, international and national authorities have 
increasingly recognized the importance of more effective 
animal health surveillance. However, limited resources in 
most countries have meant that investments into improved 
surveillance capacity have occurred largely in those coun-
tries affected by major outbreaks, such as the case with an 
outbreak of Nipah virus infection in Malaysia and of in-
fluenza A(H5N1) virus infection in Thailand, China, Viet-
nam, and Indonesia. Where these types of investments did 
occur, they were often species- and threat-specific, rather 
than to facilitate strategic enhancement of generic surveil-
lance efforts for dealing with emerging disease threats. Not 
too dissimilar from the situation in high income countries, 
institutional and administrative boundaries between the hu-
man and animal health sectors have largely prevented the 
development of integrated surveillance systems.
Regional and International Partnerships
It has been said that there have been more international 
meetings about influenza A(H5N1) virus than human cases 
of the disease. Whether this is true or not, a benefit of the 
many meetings held after the outbreaks of SARS and influ-
enza A(H5N1) virus has been a strengthening of regional 
and international professional partnerships. Clinicians, epi-
demiologists, virologists, veterinarians, and public health 
officials in East and Southeast Asia are now better connect-
ed and familiar with their colleagues than they were before 
2003: examples include the South East Asia Infectious Dis-
ease Clinical Research Network, the Mekong-Basin Dis-
ease Surveillance System, increasing membership of East 
and Southeast Asia countries in the Training Programs in 
Epidemiology and Public Health Interventions Network, 
and the establishment in 2003 of the ASEAN+3 Expert 
Working Group on Communicable Diseases (39,40). Net-
works of trusted colleagues are a powerful force for shar-
ing expertise, clearing confusion, and bridging divides, and 
these newly formed partnerships are perhaps one of the 
greatest unquantified achievements of the last decade.
To coordinate and harmonize the diversity of initia-
tives spawned by SARS, the WHO South East Asia Of-
fice and Western Pacific Office jointly developed the Asia 
Pacific Strategy for Emerging Diseases in 2005. This plan 
provides a common framework for strengthening national 
and regional surveillance and response capacity for emerg-
ing infectious diseases in the 48 countries of the Asia Pa-
cific Region; it was revised and re-endorsed by the WHO 
Regional Committees in 2010.
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A more troublesome dimension of international part-
nerships since 2003 has been the dispute over the sover-
eignty and sharing of pathogen samples. Although these 
disputes have not benefited disease surveillance in the short 
term, they do have a legitimate basis, and it must be hoped 
that in the medium term, an airing and resolution of these 
issues will result in greater trust, improved surveillance, 
and a more equitable distribution of benefits. In this con-
text, the ratification in 2011 of WHO’s Pandemic Influenza 
Preparedness Framework for the Sharing of Influenza Vi-
ruses and Access to Vaccines and Other Benefits is a major 
step forward.
Conclusions
A major shift, from West to East, is underway in the 
global center of gravity: East and Southeast Asia are be-
coming the dominant force of economic, social, and envi-
ronmental change. While rapid development has brought 
East and Southeast Asia many benefits, it has also resulted 
in widening health inequalities, environmental degradation, 
increased migration and urbanization, and a concentration 
of persons, food production, and economic activity. These 
changes might facilitate the emergence and transmission of 
new pathogens, but it would be simplistic and disingenuous 
to present the extensive changes in East and Southeast Asia 
as inevitably increasing the risk of emerging infectious dis-
eases. It seems likely that the probability of new emerging 
infections may be reduced by many of these socioeconom-
ic changes, such as urbanization and the industrialization 
and commercialization of agriculture and food production; 
however, the scale and effect of any individual emergence 
event may increase because of a greater concentration and 
connectivity of livestock and persons. Surveillance and 
response capacities have improved in the last decade, and 
East and Southeast Asia are far better prepared to detect and 
respond to emerging infectious diseases. However, we are 
still lacking the tools and methodologies to produce a suffi-
ciently refined assessment of the distribution and profile of 
disease emergence risks that encompasses geographic het-
erogeneity; the interaction of different drivers of pathogen 
evolution, crossover, and dispersion; and dynamic systems 
and the uncertainty inherent in such assessments. Given 
the continued scale and pace of change in East and South-
east Asia, it is vital that the capacity to predict and identify 
biologic threats and to protect the public’s health does not 
stagnate as the memory of SARS fades.
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